‍BOSTON, MA - AG Mednet, the leading provider of clinical collaboration and workflow solutions for clinical trials, is pleased to announce the appointment of John Paul (JP) Lee as its new Chief Operating Officer. JP brings with him over 15 years of experience in the technology space, where he has developed a reputation for driving transformation, efficiency, and scalability in high-growth organizations. JP takes over from Brian Zabin who is returning to the U.S. Government and will continue the important activities he was doing prior to joining AG Mednet.

"JP Lee is an exceptional leader in the tech industry," said Abraham Gutman, CEO of AG Mednet. "His unmatched track record of strategic execution, delivering productivity improvements, and leading leaders makes him the ideal person to take on the role of Chief Operating Officer at AG Mednet."

JP joins AG Mednet from Common Energy in New York, where he served as COO of the community solar startup that manages solar farms on behalf of solar developers. Prior to that, he worked with world-renowned consulting firms McKinsey & Company and Gerson Lehrman Group (GLG). JP holds an MBA from the Kellogg School of Management at Northwestern University.

"We are confident that JP's expertise will help take AG Mednet and the Judi clinical workflow ecosystem to new heights," said Gutman. "His strategic thinking and experience combined with our company's continued commitment to client centricity and orchestrated collaboration will further the accelerated momentum of AG Mednet and the proven Judi platform.

As Chief Operating Officer, JP will be responsible for driving AG Mednet's operational strategy and ensuring continued successful trial deployments for our global clients.

"AG Mednet is revolutionizing the clinical trial process through Judi, its proven, innovative clinical trial collaboration platform," said Lee. "I'm excited to join this talented team and help accelerate the development of innovative therapies for patients worldwide."

‍

‍

About AG Mednet

AG Mednet is revolutionizing the clinical trial process through Judi, the innovative clinical trial collaboration platform. Designed to empower the ecosystems that drive clinical research, the proven platform Judi streamlines workflows, facilitates communication, and accelerates the development of novel therapies for patients. The proven Judi platform is trusted by 19 of the top 20 global biopharmaceutical sponsors and 5 of the top 6 global CROs and enables clinical teams around the world to come together to seamlessly manage complex workflows in endpoint adjudication, eligibility, data safety monitoring, medical imaging, and other mission-critical areas of clinical development.